Natural killer cell therapies

Éric Vivier(Centre National de la Recherche Scientifique), Lucas Rebuffet(Centre National de la Recherche Scientifique), Émilie Narni-Mancinelli(Centre National de la Recherche Scientifique), Stéphanie Cornen(Innate Pharma (France)), Rob Igarashi(AVEO Oncology (United States)), Valeria R. Fantin(AVEO Oncology (United States))
Nature
February 21, 2024
10.1038/s41586-023-06945-1
Cited by 404Open Access
Full Text

Abstract

Related Papers

Up on the tightrope: natural killer cell activation and inhibition
Lewis L. Lanier|Nature Immunology|2008|1.6k
Adaptive immune features of natural killer cells
Joseph C. Sun, Joshua Beilke, Lewis L. Lanier|Nature|2009|1.6k
The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor
Stephan Gasser, Sandra Oršulić, Eric J. Brown et al.|Nature|2005|1.3k
MHC class I molecules and kirs in human history, health and survival
Peter Parham|Nature reviews. Immunology|2005|1.2k
The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
Lewis L. Lanier, A M Le, CI Civin et al.|The Journal of Immunology|1986|1.1k